Publications by authors named "F Passiglia"

Claim this Profile
A
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry.
Francesco Passiglia, Maria Lucia Reale, Giulia Pasello, Giuseppe Viscardi, Ilaria Attili

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.
Claudio Sini, Alessandro Russo, Diego Cortinovis, Lucia Anna Muscarella, Marcello Tiseo, Francesco Passiglia

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study.
Igor Gomez-Randulfe, Federico Monaca, Ornella Cantale, Maria Lucia Reale, Loredana Mrak, Francesco Passiglia

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone metastases in NSCLC: Modern paradigms in management and supportive care.
Gabriele Minuti, Giorgia Pasqualini, Alice Avancini, Niccolò Giaj-Levra, Francesca Colonese, Francesco Passiglia

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer.
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, Jessica Insolda, Ilaria Mariangela Scaglione, Francesco Passiglia

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis